The Effects of Fenugreek Extract (Fenobet) on Metabolic Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The current study is a three-blind, randomized clinical trial study that will be conducted on 60 people with metabolic syndrome. The eligible participants were allocated randomly to one of the two study groups (Fenobet, Placebo). Then, the eligible people were in one of two groups 1) receiving fenugreek extract, 2), receiving placebos and were examined for 8 weeks. At baseline and after two months of intervention, biochemical parameters, and anthropometric indices will be measured.
Epistemonikos ID: cae7ac4f3b57ebb6de7727527bc4353cc9b3bc07
First added on: May 15, 2024